IRIS UniCatt

D'Alo', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.237
EU - Europa 4.861
AS - Asia 1.901
SA - Sud America 285
OC - Oceania 158
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.514
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.099
DE - Germania 1.816
CN - Cina 939
SE - Svezia 675
IT - Italia 617
SG - Singapore 456
UA - Ucraina 302
GB - Regno Unito 263
FR - Francia 247
PL - Polonia 242
BR - Brasile 241
IE - Irlanda 159
FI - Finlandia 153
IN - India 147
AU - Australia 137
CA - Canada 116
ID - Indonesia 100
RU - Federazione Russa 68
TR - Turchia 55
NL - Olanda 49
AT - Austria 32
ES - Italia 27
CI - Costa d'Avorio 26
VN - Vietnam 26
BE - Belgio 25
IR - Iran 25
RO - Romania 24
CH - Svizzera 23
JP - Giappone 23
KR - Corea 23
NZ - Nuova Zelanda 21
CZ - Repubblica Ceca 16
AR - Argentina 15
GR - Grecia 15
HU - Ungheria 15
IL - Israele 14
MX - Messico 14
EG - Egitto 11
BG - Bulgaria 10
NO - Norvegia 10
PT - Portogallo 10
ZA - Sudafrica 10
AE - Emirati Arabi Uniti 9
HK - Hong Kong 9
SK - Slovacchia (Repubblica Slovacca) 9
MY - Malesia 8
CL - Cile 7
CO - Colombia 7
DZ - Algeria 7
LT - Lituania 7
EC - Ecuador 6
HR - Croazia 6
LV - Lettonia 6
BA - Bosnia-Erzegovina 5
BD - Bangladesh 5
DK - Danimarca 5
LB - Libano 5
MA - Marocco 5
NP - Nepal 5
PK - Pakistan 5
RS - Serbia 5
SA - Arabia Saudita 5
TH - Thailandia 5
GE - Georgia 4
IQ - Iraq 4
KG - Kirghizistan 4
MK - Macedonia 4
UZ - Uzbekistan 4
AM - Armenia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GH - Ghana 3
JO - Giordania 3
LK - Sri Lanka 3
ME - Montenegro 3
PY - Paraguay 3
SI - Slovenia 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
UY - Uruguay 2
A1 - Anonimo 1
BO - Bolivia 1
EU - Europa 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
MM - Myanmar 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
SC - Seychelles 1
Totale 12.511
Salva come PNG Salva come JPEG
Città #
Chandler 665
Ashburn 319
Singapore 288
Jacksonville 234
Warsaw 209
Beijing 190
Houston 165
Nanjing 157
Munich 156
Dublin 152
Dearborn 147
San Mateo 146
Ann Arbor 140
Woodbridge 137
Fairfield 129
Milan 116
Wilmington 113
Nürnberg 108
Hangzhou 103
New York 103
Rome 97
Redwood City 95
Seattle 91
Jakarta 88
Helsinki 77
Los Angeles 75
Chicago 71
Bremen 70
Nanchang 58
Boston 53
Cattolica 53
Moscow 53
Lawrence 52
Marseille 37
Kunming 36
Frankfurt am Main 35
Izmir 35
Sydney 33
The Dalles 32
Cambridge 31
Guangzhou 30
Hefei 30
Lancaster 30
London 28
Shanghai 27
Shenyang 27
Abidjan 26
Brooklyn 24
Melbourne 24
Portland 24
Princeton 23
Adelaide 22
Brisbane 22
Hyderabad 22
Phoenix 22
San Francisco 21
Toronto 21
Brussels 20
Hebei 20
Leawood 20
Auburn Hills 19
Changsha 19
Fremont 19
Jiaxing 18
Mountain View 18
São Paulo 18
Boardman 17
Redmond 17
Philadelphia 16
University Park 16
Zhengzhou 16
Hanoi 15
San Diego 15
Tianjin 15
Berlin 14
Buffalo 14
Norwalk 14
Nuremberg 14
Augusta 13
Jinan 13
Seoul 13
San Jose 12
Vienna 12
Atlanta 11
Belo Horizonte 11
Pittsburgh 11
Pune 11
Costa Mesa 10
Kansas City 10
Naples 10
Padova 10
Santa Clara 10
Wroclaw 10
Auckland 9
Bologna 9
Chengdu 9
Hermosillo 9
Lanzhou 9
Amsterdam 8
Brno 8
Totale 5.954
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.623
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 373
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 294
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 280
DNMT1-interacting RNAs block gene-specific DNA methylation 258
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 241
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 218
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 217
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 217
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 193
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 190
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 184
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 178
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 174
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 171
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 167
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 163
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 155
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 149
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 142
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 141
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 139
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 139
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 138
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 137
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 133
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 132
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 132
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 128
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 128
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 123
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 121
Epigenetic changes in therapy-related MDS/AML 118
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 118
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 118
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 118
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 117
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 115
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 114
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 113
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 112
PU.1 and CEBPA expression in acute myeloid leukemia. 109
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 106
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 106
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 102
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 102
Outcome of therapy-related myeloid neoplasms treated with azacitidine 101
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 101
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 100
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 99
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 99
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 97
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 95
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 94
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 94
Mantle cell lymphoma relapsing at the lymphedematous arm 92
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 90
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 90
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 90
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 89
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 85
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 85
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 84
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 83
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 81
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 80
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 77
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 77
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 75
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 73
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab 70
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 67
Aggiornamenti di Diagnostica Molecolare in Ematologia 63
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing 63
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 60
Secondary Orbital and Intraocular Lymphoma Treated With Immunochemotherapy 57
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 57
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 54
Absence of structural mutations of the BAK gene in B cell lymphomas 50
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 47
CAR-T Cell Therapy for Follicular Lymphomas 41
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 33
Case of metastatic melanoma in bone marrow smear 31
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 28
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 27
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 22
Totale 12.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.159
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202095 0 0 0 0 0 0 0 0 0 0 0 95
2020/20211.182 42 99 46 102 116 116 125 34 110 89 259 44
2021/2022903 109 84 15 32 67 37 26 138 53 74 124 144
2022/20231.931 266 270 132 333 116 222 100 146 184 39 76 47
2023/20241.693 54 266 71 92 114 201 81 109 81 151 231 242
2024/20252.588 299 205 275 146 229 114 213 149 328 227 371 32
Totale 12.647